Copyright
©The Author(s) 2019.
World J Clin Cases. Nov 26, 2019; 7(22): 3872-3880
Published online Nov 26, 2019. doi: 10.12998/wjcc.v7.i22.3872
Published online Nov 26, 2019. doi: 10.12998/wjcc.v7.i22.3872
Gene | Mutation description | Mutation type | Mutant species | Clinical significance |
BRCA1 | c.5085dupT (p.Val1696Cysfs*3) | Frameshift mutation | Heterozygous mutation | Pathogenic |
BRCA2 | No pathogenic mutations detected | / | / | / |
Ref. | Age at PS (yr) | Previous breast cancer | Procedure | Interval between PS and PPC (mo) | Follow-up time (mo) | Status | BRCA1/2 mutation |
Rebbeck et al[4] | N/A | NO | SO | 46 | N/A | N/A | BRCA1 |
N/A | NO | SO | 103 | N/A | N/A | BRCA1 | |
Casey et al[5] | 45 | NO | Hyst-BSO | 45 | 24 | DOD | BRCA1 |
38 | NO | Hyst-BSO | 67 | 24 | DOD | BRCA1 | |
48 | YES | Hyst-BSO | 21 | 11 | DOD | BRCA1 | |
44 | YES | Hyst-BSO | 13 | 48 | DOD | BRCA1 | |
31 | YES | BSO | 292 | 13 | DOD | BRCA1 | |
Zakhour et al[7] | 39 | NO | BSO | 65 | 27 | DOD | BRCA1 |
47 | NO | BSO | 126 | 24 | Alive | BRCA1 | |
62 | YES | BSO | 19 | 24 | Alive | BRCA1 | |
Olivier et al[10] | 60 | NO | SO | 27 | 22 | Alive | BRCA1 |
53 | NO | SO | 33 | 53 | DOD | BRCA1 | |
64 | NO | SO | 70 | 20 | Alive | BRCA1 | |
Powell et al[11]1 | N/A | N/A | BSO | 84 | 12 | DOD | BRCA1 |
N/A | N/A | BSO | 12 | 72 | DOD | BRCA1 | |
N/A | N/A | BSO | 60 | 60 | Alive | BRCA1 | |
Finch et al[12]1 | 46 | NO | Hyst-BSO | 36 | 36 | DOD | BRCA2 |
44 | YES | BSO | 12 | 48 | DOD | BRCA1 | |
38 | NO | BSO | 60 | 36 | DOD | BRCA1 | |
51 | YES | Hyst-BSO | 48 | 24 | Alive | BRCA1 | |
36 | NO | Hyst-BSO | 24 | 24 | Alive | BRCA1 | |
55 | YES | BSO | 24 | 24 | DOD | BRCA1 | |
51 | NO | BSO | 240 | 12 | Alive | BRCA1 | |
Meeuwissen et al[13] | 61 | N/A | SO | 14 | 12 | DOD | BRCA1 |
Rabban et al[14] | N/A | N/A | BSO | 62 | 24 | DOD | BRCA1 |
N/A | N/A | BSO | 22 | 45 | Alive | BRCA1 | |
Hill et al[15]1 | 56 | N/A | BSO | 60 | 36 | Alive | BRCA1 |
Powell et al[16]1 | N/A | N/A | BSO | 60 | N/A | N/A | BRCA1 |
N/A | N/A | BSO | 60 | N/A | N/A | BRCA1 | |
Rhiem et al[17] | 57 | NO | BSO | 26 | 12 | Alive | BRCA1 |
- Citation: Ma YN, Bu HL, Jin CJ, Wang X, Zhang YZ, Zhang H. Peritoneal cancer after bilateral mastectomy, hysterectomy, and bilateral salpingo-oophorectomy with a poor prognosis: A case report and review of the literature. World J Clin Cases 2019; 7(22): 3872-3880
- URL: https://www.wjgnet.com/2307-8960/full/v7/i22/3872.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i22.3872